Lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer: A systematic review
Citation
Madden, R, Kosari, S, Peterson, G et al 2018, 'Lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer: A systematic review', International Journal of Clinical Pharmacology and Therapeutics, vol. 56, no. 2, pp. 72-80.Year
2018ANU Authors
Field of Research
- Health Information Systems (Incl. Surveillance)
